Jeffrey Dunn, Pharm.D., MBA, discusses how the overall issues for assisted reproductive technologies (ARTs) encompass a range of challenges, including access, affordability, efficacy and ethical considerations, and the need for continued research and improvement in treatment protocols
Video content above is prompted by the following:
Get the latest industry news, event updates, and more from Managed healthcare Executive.